We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
–
AUM
$1.44B
AUM Growth
-$2.12B
Cap. Flow
-$2.99B
Cap. Flow %
-207.51%
Top 10 Hldgs %
44.76%
Holding
213
New
76
Increased
14
Reduced
26
Closed
68

Top Buys

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$15.9M
2
COCH icon
Envoy Medical
COCH
+$11.4M
3
PFPT
Proofpoint, Inc.
PFPT
+$11.4M
4
MBAC
M3-Brigade Acquisition II Corp.
MBAC
+$9.73M
5
FACA
Figure Acquisition Corp. I
FACA
+$9.49M

Top Sells

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$101M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$60.7M
3
RP
RealPage, Inc.
RP
+$58.4M
4
WTW icon
Willis Towers Watson
WTW
+$54.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$48.3M

Sector Composition

Rank Sector Weight
1 Healthcare 3.65%
2 Consumer Discretionary 3.39%
3 Technology 3%
4 Financials 2.96%
5 Communication Services 2.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSPQ.U
101
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
$538K 0.04%
54,000
-196,000
-78% -$1.96M
TBCP
102
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$524K 0.04%
+54,000
New +$529K
LGAC
103
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$489K 0.03%
+50,000
New +$491K
ACTDU
104
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$489K 0.03%
+48,000
New +$486K
HLAH
105
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$488K 0.03%
50,000
-250,000
-83% -$2.44M
HTPA
106
DELISTED
Highland Transcend Partners I Corp.
HTPA
$486K 0.03%
+50,000
New +$491K
GTPB
107
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$478K 0.03%
+48,000
New +$476K
GSQD
108
DELISTED
G Squared Ascend I Inc.
GSQD
$474K 0.03%
+48,000
New +$472K
FRXB
109
DELISTED
Forest Road Acquisition Corp. II
FRXB
$470K 0.03%
+48,000
New +$470K
FATH
110
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$467K 0.03%
+2,400
New +$471K
LBTYA icon
111
Liberty Global Class A
LBTYA
$3.52B
$466K 0.03%
17,151
-169,260
-91% -$4.57M
CORZ
112
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$433K 0.03%
+44,000
New +$434K
MBAC.WS
113
CALL
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$385K 0.03%
+333,333
New +$279K
COCHW icon
114
CALL
Envoy Medical Warrant
COCHW
$376K 0.03%
+391,665
New +$279K
REVHU
115
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$362K 0.03%
36,000
-64,000
-64% -$648K
FACA.WS
116
CALL
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$300K 0.02%
+217,375
New +$284K
VTIQ
117
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$220K 0.02%
22,000
-78,000
-78% -$772K
MMAC
118
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$204K 0.01%
+7,500
New +$162K
ISEE
119
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$189K 0.01%
+30,000
New +$194K
GNW icon
120
Genworth Financial
GNW
$3.86B
$39K ﹤0.01%
10,000
– –
DMYQ.WS
121
CALL
DELISTED
dMY Technology Group, Inc. IV Redeemable warrants, each whole warrant exercisable for one share of C
DMYQ.WS
$27K ﹤0.01%
+19,200
New +$25.3K
AUS.WS
122
CALL
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$23K ﹤0.01%
+18,749
New +$27.2K
AAL icon
123
PUT
American Airlines Group
AAL
$10B
– –
-310,000
Closed -$7.41M
ATEX icon
124
CALL
Anterix
ATEX
$2.19B
– –
-100,800
Closed -$4.75M
BMRN icon
125
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-25,000
Closed -$1.89M
3 4
5
6 7

Similar funds

PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return

DLD Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, DLD Asset Management held 213 positions worth $1.44B, down 60% from $3.56B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

DLD Asset Management withdrew a net $2.99B in Q2 2021, closing 68 positions and reducing 26 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $101M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.6% of assets, down from 4% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, DLD Asset Management opened a new position in Envoy Medical worth $11.4M.

  • DLD Asset Management's largest Q2 2021 buy was Envoy Medical: 1,175,000 shares worth $11.4M.
  • DLD Asset Management added most to Kansas City Southern in Q2 2021, an estimated $15.9M increase.
  • DLD Asset Management's biggest Q2 2021 reduction was Willis Towers Watson, cutting an estimated $54.4M.
  • DLD Asset Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $101M.
  • DLD Asset Management's ten largest holdings make up 45% of its $1.44B portfolio in Q2 2021.
  • DLD Asset Management opened 76 new positions and closed 68 in Q2 2021.
  • DLD Asset Management's portfolio value fell 60% quarter-over-quarter to $1.44B.

Based on DLD Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.